Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer.

被引：0
|
作者：
Osterlind, K
Sánchez, JM
Zatloukal, P
Hamm, J
Belani, CP
Kim, E
Felip, E
Johri, A
Berton, M
Sklenar, I
机构：
[1] Herlev Univ Hosp, DK-2730 Herlev, Denmark
[2] Hosp Germans Trias & Pujol, Barcelona, Spain
[3] Univ Hosp Na Bulovce, Prague, Czech Republic
[4] Norton Healthcare Hosp Inc, Louisville, KY USA
[5] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Vall Hebron Univ Hosp, Barcelona, Spain
[8] Novartis Pharmaceut Corp, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：647S / 647S
页数：1
相关论文
共 50 条
  • [41] Adaptive dose escalation for non-small cell lung cancer patients treated with VMAT
    Tambe, N. S.
    Pires, I. M.
    Moore, C.
    Wieczorek, A.
    Upadhyay, S.
    Beavis, A. W.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1572 - S1573
  • [42] Phase II trial of bevacizumab, cisplatin, and pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Nishizawa, Hironari
    Gyotoku, Hiroshi
    Uenami, Takeshi
    Kobayashi, Hlroshi
    Kudo, Kelta
    Tambo, Yuichi
    Horilke, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Phase II trial of bevacizumab plus docetaxel in patients with previously treated nonsquamous non-small cell lung cancer.
    Ohyanagi, Fumiyoshi
    Tanimoto, Azusa
    Sakatani, Toshio
    Kawano, Yuko
    Saito, Ryota
    Kaburaki, Kyohei
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.
    Komaki, R.
    Blumenschein, G. R.
    Wistuba, I. I.
    Lee, J. J.
    Allen, P.
    Wei, X.
    Welsh, J.
    O'Reilly, M.
    Herbst, R. S.
    Tang, X.
    Meyn, R.
    Liu, D.
    Hong, W. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] A phase II study of vorolanib in combination with toripalimab in patients with non-small cell lung cancer.
    Zhao, Jun
    Li, Jianjie
    Chen, Hanxiao
    Yang, Xue
    Zhong, Jia
    Zhuo, Minglei
    Jia, Bo
    An, Tongtong
    Wu, Meina
    Wang, Ziping
    Ding, Lieming
    Mao, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer.
    Inoue, A
    Ishida, T
    Saijo, Y
    Maemondo, M
    Suzuki, T
    Kimura, Y
    Ohkouchi, S
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [47] PET IMAGING FOR DOSE ESCALATION IN NON-SMALL CELL LUNG CANCER
    De Ruysscher, D.
    van Elmpt, W.
    Ollers, M.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S89 - S89
  • [48] Phase I/II Dose Escalation Study of Immunoconjugate L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients
    Kowalski, Dariusz
    Szczylik, Cezary
    Szczesna, Aleksandra
    Ramlau, Rodryg
    Wiatr, Elzbieta
    Chao, Heman
    Demas, Steve
    Roszkowski-Sliz, Kazimierz
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S173 - S174
  • [49] A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Lilenbaum, R
    Rubin, M
    Samuel, J
    Boros, L
    Chidiac, T
    Seigel, L
    Graham, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 630S - 630S
  • [50] Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
    Westover, Kenneth D.
    Loo, Billy W., Jr.
    Gerber, David E.
    Iyengar, Puneeth
    Choy, Hak
    Diehn, Maximilian
    Hughes, Randy
    Schiller, Joan
    Dowell, Jonathan
    Wardak, Zabi
    Sher, David
    Christie, Alana
    Xie, Xian-Jin
    Corona, Irma
    Sharma, Akanksha
    Wadsworth, Margaret E.
    Timmerman, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (01): : 72 - 81
12345